Top 25 Drugs Flashcards

1
Q

Doxazosin
1, 2, 4, 8mg TAB
4, 8mg ER TAB

BPH: IR - 1mg po qd / ER - 4mg po qd
HT: IR - 1mg qd, max 16mg qd
~Expulsion of distal ureteral stone: IR 2-4mg qd pm f4wk
~Pheochromocytoma: 1-8mg po qd

  • Initial dose w/ breakfast (esp. XR)
  • Avoid activities w/ coordination until drug effects are realized.
  • Rise slowly, may cause orthostatic hypotension.
  • Syncope or loss of consciousness is possible w/ 1st dose or increased dose, esp. in upright position.
  • Report priapism to PCP immediately

Decreased BP, improvement in urinary symptoms

A

Cardura (XL)
a1 - adrenergic blocker

Selectively blocks postsynaptic a1 receptors, reducing peripheral resistance through arterial & venous dilations.
Reflex tachycardia that occurs w/ other vasodilators is infrequent because there is no presynaptic a2 blockade.
Increase urine flow by relaxing smooth muscle tone in the bladder neck & prostate.

(<1%) Hepatotoxicity, priapism

Beta-blockers, NIFEDIPINE, PDE inhibitors
CYP3A4/5 inducers
CYP3A4/5 inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Tamsulosin
0.4 mg CAP

BPH: 0.4mg qd, tit - 0.8mg qd
~Neurogenic Bladder, Bladder outlet obstruction symptoms, Ureteral stones (DC after successful expulsion)

  • Administer 30min after same meal qd as fasting increases bioavailability by 30%.
  • Pt should avoid activities that require coordination.
  • Rise slowly –>rthostatic hypotension
  • Syncope or loss of conciousness possible w/ first dose or ^dose, esp. in upright positions

AUA Symptom score, decrease in residual urine volume
increased urine flow

A

Flomax
a1 - adrenergic blocker

Closely related to QUINAZOLINE derivatives that selectively block postsynamptic a1 receptors.
Total Peripheral resistance is reduced through arterial & venous dilations.
Relex Tachycardia that occurs w/ other vasodilators is infrequent bc there is no presynaptic a2 blockade.
The drugs also < total cholesterol, ^HDL cholesterol, and may improve glucose tolerance, and reduce left ventricular mass during long-term therapy.
Increase urine flow in BPH by relaxing smooth muscle tone in the bladder neck and prostate.

(>10%) Dizziness, headache, abnormal ejeculation, rhinitis
(<1%) Retinal detachment, priapism

a1 blockers > ^hypotension risk
CYP3A4/5 inducers
CYP3A4/5 inhibitors
beta-blockers, calcium channel blockers, MAOIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Lisinopril
2.5, 5, 10, 20, 30, 40mg TAB

Acute MI: 5-10mg qd f6wk
Heart Failure: 2.5-5mg qd, tit ->40mg/d
HT: Adults - 10mg qd, tit ->80mg/d
Children - 6-16yrs 0.07mg/kg, tit->0.61mg/kg/d

  • Avoid Pregnancy
  • Use K+ supplements or salt substitute only under medical supervision
  • May cause dizziness that may worsen if dehydrated

Decreased BP

A

Prinivil, Zestril
ACE-Inhibitor, AntiHT

Competetive ACE-I. Reduces serum aldosterone, leading to decreased NA+ retention, potentiates the vasodilator kallikrein-kinin system.
Can alter prostanoid metabolism
Inhibit SNS
Inhibit tissue renin-angiotensin system

(<1%) Angioedema, birth defects, liver failure

Angiotensin-receptor blockers
K+ sparing diuretics
AZTHIOPRINE
CYCLOSPORINE
Diuretics
NSAIDS
K+ Supplements / Salt Substitutes
SACUBITRIL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Spironolactone
25, 50, 100mg TAB

Heart Failure (NYHA class 3-4): 12.5-25mg qd, tit->50mg
Edema aw/ Heart Failure: 100mg qd in single or divided doses tit->400mg/d
Nephrotic syndrome: 100mg qd, “
HT: 50-100mg qd, “
Hypokalemia: 25-100mg qd

  • May cause dizziness
  • Avoid driving/mechinery
  • Report s/s of hyperkalemia (muscle weakness, fatigue, bradycardia) and hyponatremia (confusion,dry mouth, thirst, weakness, decreased urination, hypotension)
  • Avoid K+ supplements, food/salt
  • Avoid alcohol & NSAIDs
A

Aldactone
Potassium Sparing Diuretic
Selective Aldosterone Blocker

Steroidal competitive aldosterone antagonist that acts from the interstitial side of the distal/collecting tubular epithelium to block na/k exchange, producing a delayed/mild diuresis.
Diuretic effect is maximal in states of hyperaldosteronism.
Excreation of NA and CL is increased; excretion of K and MG is decreased.
Spiranolactone has mild anti-HT activity and has demonstrated a beneficial effect in NYHA class 3/4 heart failure.

(<1%) Cardiac arrhythmia, gastric hemorrhage

K+ sparing diuretics
ACE-Is, angiotensin receptor antagonist
EPLERENONE, K+ supplements, salt substitutes
NSAIDs
DIGOXIN, SOTALOL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Losartan
25, 50, 100mg TAB

HT: Adults, initial 50mg qd, tit-> 25-100mg qd/bid
Child >6yr, 0.7mg/kg qd max 50mg qd
Reduce risk of cerebrovascular accident, in HT patients w/ left ventricular hypertrophy, PROPHYLAXIS, diabetic nepropathy: 50mg qd, tit-> 100mg qd
Diabetic nephropathy: Initial 50mg qd, tit->based on BP up to 100mg qd
~Heart Failure: Initial 12.5mg qd –> 50mg qd
~Cardiovascular event risk, reduction: Adults 50-100mg qd
~Isolated systolic HT, left ventricular HT, nondiabetic kidney disease: 50mg qd

A

Cozaar
Angiotensin 2 Receptor Antagonist
Antihypertensive

Losartan is a selective, reversible, competitive antagonist of the angiotensin 2 receptor, responsible for the physiologic effects of AT2 including VASOCONSTRICTION, aldosterone secretion, sympathetic outflow, and stimulation of renal NA reabsorption.

(>10%) Headache
(<1%) Angioedema, birth defects, hepatotoxicity, rhabdomyolysis

ACE-Is, K+ sparing diuretics
ALISKIREN
CYP2C9 &amp; CYP3A4/5 inducers+inhibitors
Diuretics
K+ supplements/Salt substitutes
NSAIDs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Valsartan
40, 80, 160, 320mg TAB

Heart Failure: 40mg bid, tit–>320mg/d
HT: 80-160mg qd, tit->320mg qd
MI: 20mg bid, tit-> 320mg qd

  • Do not DC abruptly
  • Use K+ supplements /salt ONLY under medical supervision.
  • Dizziness
  • Avoid driving/machinery
  • Avoid Alcohol & NSAIDs

Decreased BP, signs/symptoms of Heart Failure

A

Diovan
AT2 Receptor Antagonist

Valsartan is a selective, reversible, competitive antagonist of the AT2 receptor, which is responsible for the physiologic effects of AT2, including: vasoconstriction, aldosterone secretion, sympathetic outflow, and stimulation of renal NA reabsorption.

(>10%) Dizziness
(<1%) Angioedema, rhabdomyolysis

K+ sparing diuretics
ACE-I's
K+ supplements / salt
NSAIDs
DIURETICS
ALISKIREN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Nifedipine
30, 60, 90mg XR TAB
10, 20mg CAP

HT: Adults XR30mg qd
Children 0.25mg/kg qd
Stable Chronic Angina: XR30-60mg qd
Variant angina: XR30-60mg qd
~Raynaud phenomenon: XR30-60mg qd
  • Take Adalat CC on empty stomach
  • avoid GRAPEFRUIT
  • Report s/s of hypotension, excerbation of angina, peripheral edema, fatigue,
  • Avoid sudden discontinuation of drug, can cause rebound HT
  • Dizziness, avoid driving/machinery
A

Adalat CC, Procardia XL
Calcium Channel Blocker

Nifedipine is a calcium ion influx inhibitor that selectively inhibits the transmembrane influx of calcium ions into cardiac muscle and smooth muscle.
Does not alter serum calcium concentrations.

(>10%) Flushing, Headache, Perepheral Edema, Dizziness
(<1%) Aplastic anemia, thrombocytopenia, angina, tachycardia

NSAIDs
Beta-Blockers
CLOPIDOGREL
CYP3A4/5 inducers+inhibitors
TACROLIMUS
QUINIDINE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
Nitroglycerin
2.5, 6.5, 9mg XR CAP
0.3, 0.4, 0.6mg SL TAB
0.1-0.8mg/h Transdermal Patch 24hr
0.4mg/actuation Sublingual Solution
2% Transdermal Ointment
400mcg/spray Translingual Aerosol Solution
0.4% Rectal Ointment

Angina, prophylaxis: XR2.5-6.5mg tid-qid
SL 1tab or 1-2sprays 5-10min before activity (which may induce angina
Transdermal, 0.2-0.4mg/h worn topically 12-14h per day,
Acute Angina: SL 1tab or 1-2 sprays @ first signs of angina, repeat q5min if needed for a total of 3 tabs or doses in 15min

  • Sit prior to using SL tablets, SL aerosol, or spray
  • Tab should be dissolved under tongue or buccal pouch at FIRST sign of angina. DONT SWALLOW OR CHEW
  • Do not drink or eat after placement of tabs.
  • Do not inhale, spit out or rinse mouth after use.
  • Rise slowly
  • Allow 10-12hr drug-free interval
  • Avoid concurrent use of ALCOHOL, CNS depressants, antiHT’s, or other drugs that cause hyptension
  • Ointment may stain clothing.
A

MInitran, NItro-Dur, Nitrostat
Nitrate, Antianginal

Nitroglycerin is believed to be converted to Nitric Oxide by Vascular endothelium. NO activates guanylate cyclase, increasing cyclic GMP that in turn decreases intracellular calcium, resulting in direct relaxation of vascular smooth muscle.
In myocardial ischemia, nitrates dilate large epicardial vessels, enhance collateral size & flow, and reduce coronary vasoconstriction.

(>10%) Headache
(<1%) ^ intracranial pressure, severe hypotension, syncope, methemoglobinemia

Phosphodiesterase inhibitors
RIOCIGUAT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Digoxin

  1. 5, 125, 187.5, 250MCG TAB
  2. 05mg/ml SOLUTION

AFIB: LD of 0.25mg po q2h to a total dose of 1.5mg, then 0.125-0.375mg qd

Heart Failure: Premature infant/children varies greatly
Adults: LD of 0.5-0.75mg once, then 0.125-0.375mg q68 for response, followed by 0.125-0.5mg qd

Supraventricular tachyarrythmia: LD of 0.75-1.5mg (divided into 3 doses, 1/2 total dose initially, followed by 1/4 total dose at q68 intervals later), then 0.125-0.5mg qd

~Fetal Tachycardia, supraventricular tachycardia: 0.125-0.375mg qd (administered to mother)

A

Lanoxin
Digitalis Glycoside

Digitalis Glycosides exert positive inotropic effects through improved availability of calcium to myocardial contractile elements, thereby increasing cardiac output in heart failure.
Antiarrthmic actions are caused by an increase in AV nodal refractory period via increased VAGAL tone, sympathetic withdrawal and direct mechanisms

(<1%) Cardiac dysrhythmias, psychosis, seizures

Beta Blockers
Diuretics
P-glycoprotein Inducers+inhibitors
Antacids, bile acid sequestrants
SUCRALFATE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Latanoprost
0.005% Ophthalmic Solution

Ocular Hypertension, Open-Angle Glaucoma: 1d into affected eye qd pm

  • Wash Hands & remove contact lenses before use
  • Pull lower lid of your eye to form pocket. Hold dropper close to your eye w/ other hand. Gently close eye.
  • Place index finger over the inner corner of eye for 1 min.
  • Do not rinse or wipe dropper or allow it to touch anything including eye.
  • Put cap on bottle immediately

REDUCTION IN IOP

A

Xalatan
Prostaglandin
Antiglaucoma Agent

Prostaglandin F2-alpha analog.
Believed to reduce IOP by increasing the outflow of aqueous humor.
Studies suggest that the main MOA is increased uveoscleral outflow, exact MOA UNKNOWN.

(>10%) Blurred vision, itching, sensation of foreign body in eye, hyperpigmentation of eyelid, iris pigmentation
(<1%) Macular retinal edema, diplopia, keratitis.

PILOCARPINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Azelastine
0.1%, 0.15% Nasal Spray
137 mcg/actuation

Perennial allergic rhinitis / Vasomotor Rhinitis: 2sprays pn bid
Seasonal allergic rhinitis: 1-2sprays pn bid

Avoid spraying in eyes.
Possible Somnolence; avoid alcohol use and hazardous activities.
Proper instillation; PRIME spray w/ initial use or if not used for 3+ days
Blow nose prior to use
Do NOT spray into wall seperating nostrils
Taste disturbances

DECREASE IN RHINITIS SYMPTOMS

A

Astelin
Antihistamine

Azelastin is a selective H1-receptor antagonist that blocks release of histamine cells.
Inhibits other mediators of allergic rxns and reduces chemotaxis/eosinophil activation.

Common - Bitter taste in mouth, headache, somnolence

CIMETIDINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Gemfibrozil
600mg Tablet

Coronary Arteriosclerosis
Prophylaxis-familal combined hyperlipidemia
Familial type V hyperlipoproteinemia-Fredrickson type IV hyperlipoproteinemia
600mg po BID

Take 30min before BF and DIN.
Report signs of rhabdomyolysis, JAUNDICE, or renal failure

  1. Reduction in TG levels
  2. Reduction in total cholesterol
    Increase in HDL cholesterol
A

Lopid
Antihyperlipidemic

Fibric acid derivatives activate PPARalpha -> increases lipolysis and elimination of TG-rich particles by activating lipoprotien lipase & Reducing production of opoprotein C3.
Activation of PPARalpha also induces an increase in the synthesis of apoproteins A1 and A2 and HDL-cholesterol.

Common - Indigestion
RBS - Rhabdomyolysis, cholithiasis, hepatotoxicity, mood disorder, impotence, agranulocytosis

STATINS (HMG-CoA reductase inhibitors)
Colchicine, Fibrates, Cholestyramine, colestipol
CYP1A2, CY2C19, CYP2C8, CYP2C9 substances
GLYBURIDE
CYP3A4/5 inducers/inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
Niacin
250mg, 500mg ER Capsule
50, 100, 250, 500mg Tablet
250, 500, 750, 100mg ER Tablet
100, 1000g Oral Powder

Coronary Arteriosclerosis / Hypercholesterolemia: 500mg po qd
Dyslipidemia: IR 100-100mg po TID
ER 500-2000mg qd hs
MI, secondary prophylaxis: ER 500-2000mg qd hs

Start w/ low dose and titrate based on flushing tolerability.
Avoid alcohol & warm beverages to reduce flushing.
DC for several days, need to restart on lower dose.
Aspirin or NSAID 30min prior to niacin can reduce flushing.
Take HS w/ low-fat snack to help w/ flushing

A

Niaspan / SLO-Niacin
Antihyperlipidemic

Not well Defined.
Partial inhibition of release of free fatty acids from adipose tissue. Increased lipoprotein lipase activity.
Decrease rate of hepatic synthesis of VLDL & LDL

Common - Flushing
RBS - Hypophosphatemia, hepatotoxicity, rhabdomyolysis

Statins
Colchicine
Cholestyramine
Colestipol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Metoprolol
25, 50, 100mg Tablets
25, 50, 100, 200mg XR Tablets

Angina: 50mg bid or XR 100mg qd
HF: 12.5-25mg XR po qd f2w
HT: 50mg bid
XR 25-100mg po qd
Acute MI (AMI): 25-50mg q6-12h, convert to bid dosing over 2-3days or XR dosing w/ max dose of 200mg qd

Take on an empty stomach & avoid alcohol.
Avoid abrupt discontinuations, exacerbations of angina may occur.
Report signs of hypotension, HF, or agina w/ initial dose/dose changes.
Advise DIABETIC patients to carefully follow sugar levels.

Decreased BP, reduction in chest pain.
Decreased angina attacks, reduction in use of nitroglycerin for chest pain.
Improvement in s/s of HF.

A

Toprol XL
Beta Blocker, Cardioselective

Metoprolol is a cardioselective B-Blocker used in arrhythmias, HT, angina, & HF.
Effective in decreasing post-MI mortality.

Common - Dizziness, fatigue, hypotension.
RBS - Heart Failure

Alpha-Blockers, Fentanyl
Amiodarone, dronedarone.
Anti-DIABETIC drugs
CCB's, quinidine, Clonidine, CYP2D6 inhibitors
NSAIDS
Venlafaxine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Carvedilol
3.125, 6.25, 12.5, 25mg Tablet
10, 20, 40, 80mg XR Capsule

Heart Failure: 3.125mg bid
HT: 6.25mg bid, max 25mg bid
XR 20mg bid, MAX 80mg qd
Impaired LVentricular fxn post MI: 3.125-6.25mg bid,
XR 10-20mg qd AM, max 80mg qd

Take w/ food or milk.
Report s/s of HF, bradyarrhthmias, bronchospasm, hypoT, syncope, or angina w/ initial dose or changes.
Avoid abrupt DC.
Avoid driving/machinary/danger
Diabetic patients should carefully follow blood sugar

Decreased BP and HR
Reduction in chest pain, angina attacks, nitroglycerin use
Improvement in s/s of HF

A

Coreg / Coreg CR
Alpha/Beta Blocker

Carvedilol is a selective Alpha and nonselective Beta blocker that decreases AV NODAL CONDUCTION in supraventricular tachycardias and blockade of catecholamine-induced dysrhythmias.

Common - Cold extremities, dizziness, ED, fatigue, hypoT, weight gain
RBS - HF, hepatotoxicity, Steven-Johnson syndrome

CCB, clonidine, quinidine, amiodarone, dronedarone
P-glycoprotein inducers / inhibitors / Substrates
CYP2D6 inhibitors
Insulin, oral hypoglycemic agents, NSAIDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Amlodipine
2.5, 5, 10mg Tablet

HT: 5-10mg qd
Stable & Varient Angina: 5-10mg qd

Report s/s of hypotension or angina w/ ID and changes.
Avoid alcohol w/ drug.
Report s/s of edema, fatigue, hypotension or hepatic dysfunction.
DIZZINESS - worse if too much water loss from sweat/diarrhea/vomiting
Avoid dangerous activities w/ dizziness.

A

Norvasc
Calcium Channel Blocker

Long acting dihydropyridine CCB w/ potent arterial and coronary VASODILATING properties.

Common - Peripheral and pulmonary edema.
RBS - Hepatotoxicity, thrombocytopenia, AMI, angina

CYP3A4/5 Inhibitors and inducers
NSAIDs

17
Q

Verapamil
40, 80, 120mg ER Tabs
120, 180, 240mg ER Tabs
100, 120, 180, 200, 240, 300, 360mg 24HR SR Caps

Angina: 80-120mg TID
XR 180mg qd hs
Atrial arrhythmia or paroxysmal supraventricular tachycardia prophylaxis: 240-320mg/d in 3-4 divided doses
HT: 80mg TID
XR 180-200mg qd hs
SR 180mg qd am

Do not crush or chew XR products.
May be sprinkled on food & swallowed w/o chewing, then water.
Report symptomatic hypotension, bradyarrhythmia, edema, syncope.
Avoid sudden DC of drug.
Rise slowly from sit/lying to avoid DIZZINESS.

Decreased BP
Inproved HR/rhythm
Reduction in chest pain, angina attacks, and use of nitroglycerin

A

Calan (SR) / Isoptin (SR)
Calcium Channel Blocker

Inhibits CALCIUM SLOW CHANNELS on vascular smooth muscle and myocardium producing relaxation of muscle and VASODILATION.
Increases myocardial OXYGEN delivery and slow CONDUCTION through AV node.

Common - Gingival hyperplasia
RBS - CHF, Heart Block, hepatotoxicity, pulmonary edema

CYP3A4/5 inducers, substrates, inhibitors
Disopyramide
BETA BLOCKERS
Amiodarone

18
Q

Diltiazem
30, 60, 90, 120mg Tab
60, 90, 120mg ER 12H Cap
120, 180, 240, 300, 360, 420mg ER 24H Cap
120, 180, 240, 300, 360, 420mg ER 24H Tab

Hypertension: ER 12H 60-120mg BID –> 360mg/d
ER 24H 120-240mg qd –> 540mg/d

Stable, Chronic angina: IR 30mg QID –> 360mg/d
ER 24H 120mg qd –> 540mg/d

Atrial Arrhthmia & Paroxysmal SV Tachycardia: 180-360mg qd

Report symptomatic hypoT, bradyA, peripheral edema, or syncope.
Various brand names w/ varying properties.
Specific to brand for meals/timing
DO NOT drink ALCOHOL w/ drug.

Decreased BP, reduction in chest pain
Decreased angina attacks
Reduction of Nitroglycerin use.

A

Cardizem / Dilacor XR / Taztia XT / Tiazac
Calcium Channel Blocker

CCB drug that decreases HR, prolongs AV nodal conduction, and decreases arteriolar & caronary vascular tone.
Negative inotropic properties

Common - Edema, Headache
RBS - HF, Heart Block, hepatotoxicity

CYP3A4/5 inducers, substrates, inhibitors
Beta Blockers
P-glycoprotein inducers / inhibitors

19
Q

Triamcinolone Topical

  1. 025%, 0.1%, 0.5% CREAM
  2. 025%, 0.1% LOTION
  3. 025%, 0.05%, 0.1%, 0.5% OINTMENT

Skin Disorders - Thin layer AAA; qd or BID

Apply thin layer to AA.
Skin should be clean/intact.
Avoid contact w/ eyes and digestion.
Do not use occlusive dressings or tight fitting clothes over site.

Improvement in clinical signs of skin disorder.

A

Triamcinolone Topical
Topical Corticosteroid

Anti-inflammatory, antipruritic, and vasoCONSTRICTIVE properties.
–> Induction of phospholipase A@ inhibitory proteins, lipocortins. These proteins control the biosynthesis of potent mediators of inflammation (prostaglandins / leukotriens . Inhibit release of their common precurser, ARACHIDONIC ACID.

RBS - HPA suppression reported when used w/ occlusive dressings over large surface area.

No DI

20
Q
Hydrocortisone Topical
1%, 2.5% Rectal Cream
0.5%, 1%, 2.5% Topical Cream
1%, 2.5% Lotion
0.5%, 1%, 2.5% Ointment

Skin Disorders / Corticosteroid responsive: Thin Layer AAA qd or BID

Apply thin layer to AA.
Skin should be clean/intact.
Avoid contact w/ eyes and digestion.
Do not use occlusive dressings or tight fitting clothes over site.

Improvement in clinical signs of skin disorder

A

Hydrocortisone Topical
Topical Corticosteroid

Anti-inflammatory, antipruritic, and vasoCONSTRICTIVE properties.
–> Induction of phospholipase A@ inhibitory proteins, lipocortins. These proteins control the biosynthesis of potent mediators of inflammation (prostaglandins / leukotriens . Inhibit release of their common precurser, ARACHIDONIC ACID.

RBS - HPA suppression reported when used w/ occlusive dressings over large surface area.

No DI

21
Q

Furosemide
20, 40, 80mg Tab
8mg/1ml, 10mg/1ml Oral Solution

Edema Related to HF / Renal Failure: Initial 20-80mg qd –> 600mg/d
+child/neonate dose

Hypertension: 40mg BID –> to patient response.
+child dose

Avoid ALCOHOL / NSAIDs.
Increased risk of SUN sensitivity, use sunblock.
Avoid coordinated movements, possible dizziness / vertigo / blurred vision.
Report s/s hypoT, decreased urine output or ototoxicity.
Severe skin reactions.
EAT HIGH K+ foods, as directed by DR.

Decreased BP, ^urine output, reduction in EDEMA
For renal failure: Increased urine, CrCL, BUN, and electrolytes.

A

Lasix
Loop Diuretic

Loop dieretic that is actively secreted via nonspecifc organic acid transport system into the lumen of the THICK ascending limb of Henle’s loop.
Decreases NA reabsorption by competing for the CL site on the NA+/K+/2Cl- co-transporter.

Common - Hyperuricemia
RBS- Neprotoxicity, ototoxicity, thrombocytopenia, tinnitus

ACE-I, Aminoglycosides
Antidiabetic drugs, Antiarrthymic agents
DIGOXIN, bile acid resins, diuretics
Lithium, NSAIDs, SGLT2 inhibitors

22
Q

Hydrochlorothiazide (HCTZ)

  1. 5mg Cap
  2. 5, 25, 50mg Tab

Edema; adjunct: 25-100mg qd in single or div. doses
+children/infant dose

HT: Initial 12.5-25mg qd –> 50-100mg qd in s/div doses
+child/infant dose

May be taken W/WO food.
Avoid ALCOHOL / NSAIDs
Take early in day to avoid nocturia.
May cause dizziness.
Report s/s of hypoT.
Eat high K+ foods during therapy

Decreased BP, reduction in edema

A

Esidrix
Thiazide Diuretic / AntiHT

Thiazides increase NA/CL excretion by interfering w/ their reabsorption in the cortical diluting segment of the nephron.

Common - HypoT, dizziness, headache
RBS - Cardiac arrhythmias, hepatitis, pancreatitis, Steven-Johnson Syndrome

ACE-I/ARB
Antiarrhythmic agends, DIGOXIN
Calcium supplements, NSAIDS
Dofetilide, Topiramate, Lithium
Carbamazepine
23
Q

Rivaroxaban
10, 15, 20mg

Prevention of thromboembolism in patients after Orthopedic surgery: 10mg qd at least 6 hours AFTER surgery for 12-14 days for knee replacement
35 days for hip replacement. Monitor CrCL

Prevention of thromboembolism in pts w/ nonvalvular AFIB: 20mg qd if CrCL >50ml/min
15mg qd if CrCl 15-50ml/min

Treatment and secondary prevention of DVT or pulmonary embolism: 15mg BID f12d, then 20mg qd

Take w/ Evening Meal.
Educate pt on s/s of bleeding & interactions with other anticoagulant/antiplatelet medications + OTC meds.
Risk of epidural anesthesia.
Doses >15 WF.
Take w/ evening meal for NONVALVULAR atrial

Prevention of clotting or recurrance of clotting
Routine monitoring of anti-coagulation tests is not necessary w/ rivaroxiaban.
Anti-Xa activity is preferred test.

A

Xarelto
Anticoagulant, Factor Xa Inhibitor

Orally bioavailable factor Xa inhibitor that selectively blocks the active site of factor Xa, and does not require a co-factor (like antithrombin 3).
Activation of factor X to factor Xa via instrinsic/extrinsic pathways plays a central role in cascade of blood coagulation.

Common - Bleeding
RBS - Syncope, major bleeding, epidural hematoma, anaphylaxis, intracranial bleeding

CY3A4/5 i/i
Antiplatelet / Anticoagulant agents
NSAIDs

24
Q

Atorvastatin
10, 20, 40, 80mg Tabs

Hyperlipidemia: 10-20mg qd –> 80mg qd

1/2 prevention of atherosclerotic CV disease: 20-40mg qd –> 80mg qd (LDL>190 or ASCVD)

2* prevention of CV events w/ patients w/ or at high risk for CAD: 80mg qd, may reduce to 40mg qd if high dose not tolerated.

Homozygous Familial hypercholesterolemia: Adults 10-80mg qd
+Children 10mg qd –> 40mg qd

Contact DR immediately if pregnancy occurs while taking.
Avoid ALCOHOL, GRAPEFRUIT, GRAPEFRUIT JUICE consumption.
Does not take place of lifestyle changes.
Notify if unexplained muscle tenderness / WEAKNESS.

Total chol / LDL-chol / TG levels
HDL- Chol levels

A

Lipitor
HMG-CoA Reductase Inhibitor

HMG-CoA Reductase inhibitors competitively inhibit conversion of HMG-CoA to mevalonate, rate limiting step in cholesterol synthesis.
A compensatory increase in LDL receptors, which bind / remove circulating LDL cholesterol results.
Production of LDL-cholesterol can decrease because of decreased rproduction of VLDL-cholesterol / increased VLDL; removal by LDL receptors.

Common - Myopathy, diarrhea, headache.

RBS - Rhabdomyolysis (skeletal muscle breaks down rapidly) , Tendon rupture

Aliskren
CYP3A4/5 i/i
Cyclosporine
HIV / HEP C protease inhibitors
P-glycoprotein substrates
25
Q

Hydralazine
10, 25, 50, 100mg Tab

HT: 10mg QID f2-4d –> 25mg QID f3-5d
Titrate to lowest effective dose at interval of 1 week, max 300mg/d
+child dose

No ALCOHOL.
Avoid sudden d/c –> rebound HT
Dizziness.
Report pain/palpitations, s/s of tachyarrhythmia, hypoT, agranulocytosis, sytstemic lupus erythematosus, or hepatoxicity.

Decrease in SYSTOLIC / DIASTOLIC BP.
Improvement in s/s of HF

A

Apresoline
Peripheral Vasodilator

Vasodilator that reduces total peripheral resistance by direct action on vascular smooth muscle, w/ greater effect on ARTERIOLES > Veins.

RBS - Agranulocytosis, hepatotoxicity, leucopenia, systemic lupus erythmatosus

NSAID
Furosemide
METOPROLOL PROPANOLOL